23,338,039
Vote Records
27,979
Companies
11,817
Funds
4,051
Managers

Home › Companies › GeneDx Holdings Corp. › 2025-2026

GeneDx Holdings Corp. 2025-2026 Proxy Voting Records

Download data (CSV): ballot items · votes by manager · column guide.

Compiled from SEC Form N-PX filings and GeneDx Holdings Corp.’s Form 8-K, filed June 23, 2026 (Item 5.07 on EDGAR). Page generated November 20, 2026.

  • 7Reported items
  • 328Asset managers, any item
  • 1,786Fund votes
  • June 18, 2026Meeting date

Results at a glance

Meeting of June 18, 2026: 3 items on GeneDx Holdings Corp.’s Form 8-K, filed June 23, 2026: 3 passed (calculated).

Dissent

Significant dissent: 1 director (24.3% against).

Dissent tiers, on the company’s own Form 8-K tally (support = FOR ÷ (FOR + AGAINST), or FOR ÷ (FOR + WITHHELD) on a withhold ballot; abstentions and broker non-votes excluded): shareholder proposals with 15% support or more are notable, 25% significant, 40% high; director nominees with 10% or more against or withheld are notable, 20% significant; say-on-pay under 80% support is notable, under 70% significant; equity and compensation plans with 15% or more against are notable, 25% significant; any other item the board put forward with 15% or more against is notable. How this is decided

Proxy season: 2024-2025 2025-2026

Activist investors: Corvex (13D, 17.9%, as of May 22, 2026)

Explore GeneDx Holdings Corp. in the interactive database Compare manager voting policies

Official 2025-2026 meeting results reported by GeneDx Holdings Corp.

These tallies are GeneDx Holdings Corp.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed June 23, 2026 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

GeneDx Holdings Corp. — official shareholder meeting results, meeting held June 18, 2026
Ballot itemForAgainst AbstainWithheldBroker non-votesSupport (of votes cast)Reported outcomeVoting standard
Elect Director: Katherine Stueland 18,325,894---- 5,893,4663,409,327 76%Passed (calculated)—
2. The Auditor Ratification Proposal — To ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026 27,466,639158,8843,164 ---- 99.4%Passed (calculated)—
3. Advisory Vote on Executive Compensation of Named Executive Officers Proposal — To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the Company's definitive proxy statement 22,705,9461,471,59341,821 ---- 94%Passed (calculated)—

Source: GeneDx Holdings Corp., Form 8-K, filed with the SEC on June 23, 2026 — read the filing on EDGAR.

How asset managers voted at the GeneDx Holdings Corp. 2025-2026 meeting

328 asset managers disclosed a vote on at least one GeneDx Holdings Corp. item in their SEC Form N-PX filings. Each item below shows how many of them voted on it, and how. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of GeneDx Holdings Corp.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.

Elect Director: Katherine Stueland

Calculated outcomeDIRECTOR ELECTIONSPassed (calculated)

Combines 6 wordings of this item as funds reported it.

76% Majority: yes · of votes cast

FOR 76%WITHHELD
FOR: 18,325,894WITHHELD: 5,893,466
Details: description as filed, official tally, votes by 102 asset managers

Description as filed by funds: Election of Director: Katherine Stueland

GeneDx Holdings Corp.’s own tally for this item (“Elect Director: Katherine Stueland”): 18,325,894 for, 5,893,466 withheld, per its Form 8-K filed June 23, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 76% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 102 asset managers below reported 6,293,672 for, 2,149,103 withheld, 401,788 abstained.

FORWITHHOLD
FOR: 6,293,672ABSTAIN: 401,788WITHHOLD: 2,149,103
Largest asset managers voting on “Election of Director: Katherine Stueland” at GeneDx Holdings Corp., 2025-2026
Asset managerForAgainst AbstainWithheldVote
ARK ETF Trust1,227,6630 00For
Vanguard1,023,9880 130For
Fidelity632,8140 075,525Mixed
BlackRock502,4090 00For
MUTUAL FUND SERIES TRUST00 0478,123Withhold
Invesco459,9480 00For
MFS00 0352,688Withhold
Capital Group335,4610 00For
BNY Mellon292,0590 0721For
OBERWEIS FUNDS00 0247,300Withhold
Putnam229,0240 00For
HARBOR FUNDS00 222,2430Abstain
FRANKLIN STRATEGIC SERIES201,6660 00For
Columbia Threadneedle179,8470 00For
Waddell & Reed00 0173,405Withhold
Charles Schwab172,3220 00For
Royce162,4250 00For
WILLIAM BLAIR FUNDS00 0156,662Withhold
ALGER FUNDS00 0144,840Withhold
Hartford139,8160 00For
Thrivent00 0104,675Withhold
Aberdeen92,8160 00For
Dimensional00 087,558Withhold
CARILLON SERIES TRUST00 65,0670Abstain
Principal Exchange-Traded Funds00 063,520Withhold

Showing the 25 largest of 102 asset managers. All 102 are in the interactive database (link above).

Election of Directors

No official matchDIRECTOR ELECTIONS

All nominees (reported as one line). These filers reported the election of directors as a single line covering every nominee. It is not attributed to any one director, and no share total is shown for it.

100% of fund votes cast · no official result

FOR
Details: votes by 2 asset managers

The 2 asset managers below reported this as one line covering every nominee; it is not attributed to any one director, and no share total is shown for it.

Largest asset managers voting on “Election of Directors” at GeneDx Holdings Corp., 2025-2026
Asset managerForAgainst AbstainWithheldVote
NORTHERN LIGHTS FUND TRUST II10,7010 00For
Williamson Legacy Group, LLC10 00For

Advisory Vote on Executive Compensation of Named Executive Officers Proposal — To approve, on an advisory basis, the…

Calculated outcomeFund totals may overlapSECTION 14A SAY-ON-PAY VOTESPassed (calculated)

Combines 7 wordings of this item as funds reported it.

94% Majority: yes · of votes cast

FOR 94%
FOR: 22,705,946AGAINST: 1,471,593
Details: description as filed, official tally, votes by 328 asset managers

Description as filed by funds: Approval, on a non-binding advisory basis, the compensation of our named executive officers.

GeneDx Holdings Corp.’s own tally for this item (“3. The Advisory Vote on Executive Compensation of Named Executive Officers Proposal — To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the Company's definitive”): 22,705,946 for, 1,471,593 against, per its Form 8-K filed June 23, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 94% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports: 104 asset managers voting on “Approval, on a non-binding advisory basis, the compensation of our named executive officers.” at GeneDx Holdings Corp., 2025-2026
Asset managerForAgainst AbstainWithheldVote
ARK ETF Trust1,227,6630 00For
Vanguard1,023,9983 00For
Fidelity708,3390 00For
BlackRock502,4090 00For
MUTUAL FUND SERIES TRUST478,1230 00For
Invesco459,9480 00For
MFS352,6880 00For
Capital Group0335,461 00Against
BNY Mellon721292,059 00Against
OBERWEIS FUNDS247,3000 00For
Putnam229,0240 00For
HARBOR FUNDS222,2430 00For
FRANKLIN STRATEGIC SERIES201,6660 00For
Columbia Threadneedle0179,847 00Against
Waddell & Reed173,4050 00For
Charles Schwab172,3220 00For
Royce162,4250 00For
WILLIAM BLAIR FUNDS156,6620 00For
ALGER FUNDS144,8400 00For
Hartford139,8160 00For
Thrivent104,6750 00For
Aberdeen92,8160 00For
Dimensional87,5580 00For
CARILLON SERIES TRUST65,0670 00For
Principal Exchange-Traded Funds63,5200 00For

Fund voting reports, all 104 managers: 8,033,029 for, 821,521 against, 914 abstained. Showing the 25 largest; every one is in the interactive database (link above).

Institutional-manager reports: 253 asset managers voting on “Approval, on a non-binding advisory basis, the compensation of our named executive officers.” at GeneDx Holdings Corp., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Casdin Capital, LLC3,007,1640 00For
Corvex Management LP2,912,5700 00For
WESTFIELD CAPITAL MANAGEMENT CO LP964,7040 00For
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC656,7920 00For
BlackRock644,7490 00For
Amova Asset Management Co., Ltd.629,6400 00For
Invesco507,9510 00For
GEODE CAPITAL MANAGEMENT, LLC507,2670 00For
Newton Investment Management North America, LLC0478,196 00Against
MASSACHUSETTS FINANCIAL SERVICES CO /MA/365,0040 00For
Putnam355,3670 00For
Wellington298,9710 00For
SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC294,1670 00For
State Street293,9820 00For
Citadel293,1410 00For
Aberdeen278,5420 00For
RA CAPITAL MANAGEMENT, L.P.277,5980 00For
OBERWEIS ASSET MANAGEMENT INC/257,3000 00For
NOMURA INVESTMENT MANAGEMENT BUSINESS TRUST255,0080 00For
FRANKLIN ADVISERS INC245,0070 00For
Vestal Point Capital, LP226,9680 00For
First Light Asset Management, LLC226,1160 00For
Capital Group0218,730 00Against
FRED ALGER MANAGEMENT, LLC206,3470 00For
Fidelity195,1590 00For

Institutional-manager reports, all 253 managers: 16,761,690 for, 1,066,880 against, 824 abstained, 113 not voted, 7,955 1 year. Showing the 25 largest; every one is in the interactive database (link above).

Indicate, on a non-binding advisory basis, whether future advisory votes on the compensation paid by us to our named…

No official matchFund totals may overlapSECTION 14A SAY-ON-PAY VOTES

Combines 3 wordings of this item as funds reported it.

100% Fund and manager reports combined; may count the same shares twice · no official result

1 YEAR
Details: description as filed, votes by 317 asset managers

Description as filed by funds: Indicate, on a non-binding advisory basis, whether future advisory votes on the compensation paid by us to our named executive officers should be held every one, two, or three years.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice). The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

Fund voting reports: 103 asset managers voting on “Indicate, on a non-binding advisory basis, whether future advisory votes on the compensation paid by us to our” at GeneDx Holdings Corp., 2025-2026
Asset managerForAgainst AbstainWithheldVote
ARK ETF Trust00 00--
Vanguard00 00--
Fidelity00 00--
BlackRock00 00--
MUTUAL FUND SERIES TRUST00 00--
Invesco00 00--
MFS00 00--
Capital Group00 00--
BNY Mellon00 00--
OBERWEIS FUNDS00 00--
Putnam00 00--
HARBOR FUNDS00 00--
FRANKLIN STRATEGIC SERIES00 00--
Columbia Threadneedle00 00--
Waddell & Reed00 00--
Charles Schwab00 00--
Royce00 00--
WILLIAM BLAIR FUNDS00 00--
ALGER FUNDS00 00--
Hartford00 00--
Thrivent00 00--
Aberdeen00 00--
Dimensional00 00--
CARILLON SERIES TRUST00 00--
Principal Exchange-Traded Funds00 00--

Fund voting reports, all 103 managers: 14,954 for, 914 abstained, 8,731,855 1 year, 96,991 3 year, 49 unknown. Showing the 25 largest; every one is in the interactive database (link above).

Institutional-manager reports: 241 asset managers voting on “Indicate, on a non-binding advisory basis, whether future advisory votes on the compensation paid by us to our” at GeneDx Holdings Corp., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Casdin Capital, LLC00 00--
Corvex Management LP00 00--
WESTFIELD CAPITAL MANAGEMENT CO LP00 00--
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC00 00--
BlackRock00 00--
Amova Asset Management Co., Ltd.00 00--
Invesco00 00--
GEODE CAPITAL MANAGEMENT, LLC00 00--
Newton Investment Management North America, LLC00 00--
MASSACHUSETTS FINANCIAL SERVICES CO /MA/00 00--
Putnam00 00--
Wellington00 00--
SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC00 00--
State Street00 00--
Citadel00 00--
Aberdeen00 00--
RA CAPITAL MANAGEMENT, L.P.00 00--
OBERWEIS ASSET MANAGEMENT INC/00 00--
NOMURA INVESTMENT MANAGEMENT BUSINESS TRUST00 00--
FRANKLIN ADVISERS INC00 00--
Vestal Point Capital, LP00 00--
First Light Asset Management, LLC226,1160 00For
Capital Group00 00--
FRED ALGER MANAGEMENT, LLC00 00--
Fidelity00 00--

Institutional-manager reports, all 241 managers: 237,967 for, 239 abstained, 113 not voted, 17,469,202 1 year, 76,611 3 year. Showing the 25 largest; every one is in the interactive database (link above).

14A Executive Compensation Vote Frequency

No official matchFund totals may overlapSECTION 14A SAY-ON-PAY VOTES

— Fund and manager reports combined; may count the same shares twice · no official result

1 YEAR
Details: votes by 4 asset managers

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports: 1 asset manager voting on “14A Executive Compensation Vote Frequency” at GeneDx Holdings Corp., 2025-2026
Asset managerForAgainst AbstainWithheldVote
NORTHERN LIGHTS FUND TRUST II00 00--

Fund voting reports, all 1 managers: 10,701 1 year.

Institutional-manager reports: 2 asset managers voting on “14A Executive Compensation Vote Frequency” at GeneDx Holdings Corp., 2025-2026
Asset managerForAgainst AbstainWithheldVote
LEAVELL INVESTMENT MANAGEMENT, INC.00 00--
Williamson Legacy Group, LLC00 00--

Institutional-manager reports, all 2 managers: 800 1 year, 1 3 year.

Advisory Vote on Say on Pay Frequency

No official matchSECTION 14A SAY-ON-PAY VOTES

— of fund votes cast · no official result

1 YEAR
Details: votes by 3 asset managers

The 3 asset managers below reported 44,779 1 year.

1 YEAR: 44,779
Largest asset managers voting on “Advisory Vote on Say on Pay Frequency” at GeneDx Holdings Corp., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Granahan Investment Management, LLC00 00--
APG Asset Management US Inc.00 00--
CIDEL ASSET MANAGEMENT INC00 00--

The Auditor Ratification Proposal — To ratify the appointment of Ernst & Young LLP as the Company's independent…

Calculated outcomeAUDIT-RELATEDPassed (calculated)

Combines 2 wordings of this item as funds reported it.

99.4% Majority: yes · of votes cast

FOR 99.4%
FOR: 27,466,639AGAINST: 158,884

Prior year: 99.8% for (June 18, 2025 meeting) ▼ 0.4 pts

Details: description as filed, official tally, votes by 104 asset managers

Description as filed by funds: RATIFICATION OF THE APPOINTMENT OF ERNST & YOUNG LLP AS THE INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2026.

GeneDx Holdings Corp.’s own tally for this item (“2. The Auditor Ratification Proposal — To ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026”): 27,466,639 for, 158,884 against, per its Form 8-K filed June 23, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 99.4% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 104 asset managers below reported 8,841,981 for, 12,370 against, 914 abstained.

FOR
FOR: 8,841,981AGAINST: 12,370ABSTAIN: 914
Largest asset managers voting on “RATIFICATION OF THE APPOINTMENT OF ERNST & YOUNG LLP AS THE INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR ” at GeneDx Holdings Corp., 2025-2026
Asset managerForAgainst AbstainWithheldVote
ARK ETF Trust1,227,6630 00For
Vanguard1,024,0010 00For
Fidelity708,3390 00For
BlackRock502,4090 00For
MUTUAL FUND SERIES TRUST478,1230 00For
Invesco459,9480 00For
MFS352,6880 00For
Capital Group335,4610 00For
BNY Mellon292,7800 00For
OBERWEIS FUNDS247,3000 00For
Putnam229,0240 00For
HARBOR FUNDS222,2430 00For
FRANKLIN STRATEGIC SERIES201,6660 00For
Columbia Threadneedle179,8470 00For
Waddell & Reed173,4050 00For
Charles Schwab172,3220 00For
Royce162,4250 00For
WILLIAM BLAIR FUNDS156,6620 00For
ALGER FUNDS144,8400 00For
Hartford139,8160 00For
Thrivent104,6750 00For
Aberdeen92,8160 00For
Dimensional87,5580 00For
CARILLON SERIES TRUST65,0670 00For
Principal Exchange-Traded Funds63,5200 00For

Showing the 25 largest of 104 asset managers. All 104 are in the interactive database (link above).

Largest GeneDx Holdings Corp. shareholders voting in 2025-2026

Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 29,666,318 shares outstanding at the time of that meeting.

Fund voting reports: top GeneDx Holdings Corp. shareholders by shares voted on “Approval, on a non-binding advisory basis, the compensation of our named executive officers.”, 2025-2026
#Asset manager % of shares outstanding
1ARK ETF Trust 4.14%
2Vanguard 3.45%
3Fidelity 2.39%
4BlackRock 1.69%
5MUTUAL FUND SERIES TRUST 1.61%
6Invesco 1.55%
7MFS 1.19%
8Capital Group 1.13%
9BNY Mellon 0.99%
10OBERWEIS FUNDS 0.83%
Institutional-manager reports: top GeneDx Holdings Corp. shareholders by shares voted on “Approval, on a non-binding advisory basis, the compensation of our named executive officers.”, 2025-2026
#Asset manager % of shares outstanding
1Casdin Capital, LLC 10.14%
2Corvex Management LP 9.82%
3WESTFIELD CAPITAL MANAGEMENT CO LP 3.25%
4WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC 2.21%
5BlackRock 2.17%
6Amova Asset Management Co., Ltd. 2.12%
7Invesco 1.71%
8GEODE CAPITAL MANAGEMENT, LLC 1.71%
9Newton Investment Management North America, LLC 1.61%
10MASSACHUSETTS FINANCIAL SERVICES CO /MA/ 1.23%

Reported GeneDx Holdings Corp. holdings and ownership

As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row gives its source and the date its figure is as of: for Form 13F the quarter end it reports, for Schedules 13D and 13G the filing date, and for the proxy statement the date of its ownership table (or, where that date has not been read, the date the proxy was filed). The rows are therefore not all as of the same day.

GeneDx Holdings Corp. holdings and ownership disclosed for the 2025-2026 proxy season, with each row’s source and date
HolderShares % outstandingSource, as of
Keith A. Meister5,356,767 18.06%Schedule 13D, filed May 22, 2026
Meister, Keith A.5,356,767 18.06%Schedule 13D, filed May 15, 2026
BlackRock1,550,708 5.23%Form 13F, quarter ended March 31, 2026
Goldman Sachs1,334,980 4.50%Form 13F, quarter ended March 31, 2026
Vanguard Group1,189,069 4.01%Form 13F, quarter ended March 31, 2026
Citadel Advisors768,001 2.59%Form 13F, quarter ended March 31, 2026
Franklin Templeton607,221 2.05%Form 13F, quarter ended March 31, 2026
Geode Capital549,147 1.85%Form 13F, quarter ended March 31, 2026
Invesco540,229 1.82%Form 13F, quarter ended March 31, 2026
Morgan Stanley506,091 1.71%Form 13F, quarter ended March 31, 2026

Percentages above are of 29,666,318 shares outstanding, as reported by GeneDx Holdings Corp. on its Form 10-Q dated March 31, 2026 (see the filing on EDGAR). This is the count contemporaneous with the 2025-2026 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.

About this meeting

At GeneDx Holdings Corp.'s shareholder meeting held June 18, 2026, in the 2025-2026 proxy season, 328 asset managers reported votes on at least one item in their SEC Form N-PX filings, covering 1,786 separate fund positions. Their filings are grouped here into 7 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — Approval, on a non-binding advisory basis, the compensation of our named executive officers. — FOR was 94% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: GeneDx Holdings Corp.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on June 23, 2026.

Related

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from GeneDx Holdings Corp.’s 10-Q dated March 31, 2026. This page is a static snapshot rebuilt weekly on November 20, 2026; a live search always shows the current data.

GeneDx Holdings Corp. proxy season coverage: 2024-2025 · 2025-2026 (this page).

Cite this page

Proxy Votes Now, “GeneDx Holdings (WGS) 2026 Annual Meeting: Shareholder Vote Results”, https://proxyvotesnow.com/company/genedx-holdings-corp/2026 (version of November 20, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.